{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:42:20Z","timestamp":1790642540033,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T00:00:00Z","timestamp":1528761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11096-018-0670-4","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T03:16:08Z","timestamp":1528773368000},"page":"977-981","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital\u00a0in Singapore"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-3816","authenticated-orcid":false,"given":"Jun Jie Benjamin","family":"Seng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Hui Amanda","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Xin","family":"Peh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Lin","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mooi Heong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,12]]},"reference":[{"issue":"13","key":"670_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","volume":"43","author":"PA Moise-Broder","year":"2004","unstructured":"Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet. 2004;43(13):925\u201342.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"670_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1586\/eri.09.123","volume":"8","author":"C Giuliano","year":"2010","unstructured":"Giuliano C, Haase KK, Hall R. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Expert Rev Anti-Infect Therapy. 2010;8(1):95\u2013106.","journal-title":"Expert Rev Anti-Infect Therapy"},{"issue":"1","key":"670_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82\u201398.","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"670_CR4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00007691-199810000-00018","volume":"20","author":"DW Bates","year":"1998","unstructured":"Bates DW. Improving the use of therapeutic drug monitoring. Ther Drug Monit. 1998;20(5):550\u20135.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"670_CR5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2146\/ajhp090661","volume":"68","author":"KA Traugott","year":"2011","unstructured":"Traugott KA, Maxwell PR, Green K, Frei C, Lewis JS 2nd. Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. Am J Health Syst Pharm. 2011;68(4):347\u201352.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"670_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s11096-012-9614-6","volume":"34","author":"M Swartling","year":"2012","unstructured":"Swartling M, Gupta R, Dudas V, Guglielmo BJ. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. Int J Clin Pharm. 2012;34(2):282\u20135.","journal-title":"Int J Clin Pharm."},{"issue":"2","key":"670_CR7","first-page":"159","volume":"17","author":"M Suryadevara","year":"2012","unstructured":"Suryadevara M, Steidl KE, Probst LA, Shaw J. Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs. J Pediatr Pharmacol Ther. 2012;17(2):159\u201365.","journal-title":"J Pediatr Pharmacol Ther."},{"issue":"4","key":"670_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1128\/AAC.25.4.433","volume":"25","author":"GR Matzke","year":"1984","unstructured":"Matzke GR, McGory RW, Halstenson CE, Keane WF. Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother. 1984;25(4):433\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"670_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00007691-199202000-00014","volume":"14","author":"DJ Carroll","year":"1992","unstructured":"Carroll DJ, Austin GE, Stajich GV, Miyahara RK, Murphy JE, Ward ES. Effect of education on the appropriateness of serum drug concentration determination. Ther Drug Monit. 1992;14(1):81\u20134.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"670_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1093\/jac\/45.3.329","volume":"45","author":"F Pea","year":"2000","unstructured":"Pea F, Porreca L, Baraldo M, Furlanut M. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures. J Antimicrob Chemother. 2000;45(3):329\u201335.","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-018-0670-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-018-0670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T19:04:48Z","timestamp":1560279888000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-018-0670-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,12]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s11096-018-0670-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,12]]},"assertion":[{"value":"6 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}